Literature DB >> 9800435

[Polymorphism of HLA-DQA1,-DQB1 genes in Uygur and Kazak ethnic groups and comprehensive analysis of 25 related populations].

X N Zhang1, Y G Liu, D Li, X Li, R X Huang, G Q Li, D L Zhu, Z C Geng.   

Abstract

HLA-DQA1 and -DQB1 genes were investigated in two Chinese minor natinalities, Uygur and Kazak using PCR-RFLP genotyping method. Of the 8 DQA1 alleles, DQA1 *0301 was the most common in Uygurs and Kazaks. DQA1 *0401 and *0601 were the rarest alleles in Uygurs and *0601 in Kazaks. Of the 16 DQB1 alleles tested, DQB1 *0201 and *0301 were the most frequent alleles in Uygurs and Kazaks. DQB1 *0502, *05032 and *0504 in Uygurs, *05032, *0504 and *0605 in Kazaks were absent. Neither DQA1 nor DQB1 difference was found between the two populations. From the phylogenetic tree based on the gene frequencies of HLA-DQA1 and -DQB1 in Uygur, Kazak and other 25 related ethnic groups, we suggest that Uygurs and Kazaks have a closer relationship, and they are closer to Mongoloid, not Caucasoid.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9800435

Source DB:  PubMed          Journal:  Yi Chuan Xue Bao        ISSN: 0379-4172


  3 in total

1.  Virological and molecular characterization of Kaposi's sarcoma-associated herpesvirus strains from Xinjiang, China.

Authors:  X Wang; H Wang; B He; Y Hui; G Lv; L Li; H Wen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-03       Impact factor: 3.267

2.  Autosomal InDel polymorphisms for population genetic structure and differentiation analysis of Chinese Kazak ethnic group.

Authors:  Tingting Kong; Yahao Chen; Yuxin Guo; Yuanyuan Wei; Xiaoye Jin; Tong Xie; Yuling Mu; Qian Dong; Shaoqing Wen; Boyan Zhou; Li Zhang; Chunmei Shen; Bofeng Zhu
Journal:  Oncotarget       Date:  2017-05-12

3.  Extensive cutaneous iatrogenic Kaposi's sarcoma after bullous pemphigoid treatment with oral methylprednisolone: a rare Chinese case report.

Authors:  Sheng-An Chen; Lan-Ting Wang; Zi-Hua Chen; Fan-Ping Yang; Qin-Yuan Zhu; Hu-Yan Chen; Xiao-Qun Luo
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.